Press Release – Seabelife

SeaBeLife raises €1.2 M ($1.28 M) from iXLife fund and historical investors

4 November 202327 September 2023

SeaBeLife receives close to €1.4M deep tech financing from Bpifrance

16 March 202216 March 2022

Funds will enable SeaBeLife to develop pipeline of innovative molecules intended to block programmed cell death in cases of acute … Lire la suite

SeaBeLife Biotech raises € 1 million to carry onits drug developments targeting regulated cell death

28 May 2021

SeaBeLife Biotech raises € 1 million to carry onits drug developments targeting regulated cell death. Roscoff, May 17th, 2021. SeaBeLife, … Lire la suite

SeaBeLife Biotech raises € 1.5 million to develop drugs targeting regulated cell death.

9 February 202119 June 2020

SeaBeLife Biotech raises € 1.5 million to develop drugs targeting regulated cell death. Roscoff, June 15, 2020. SeaBeLife, a pharmaceutical … Lire la suite